Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous synovial mesenchymal stem cell injection for knee osteoarthritis
jRCT2033230017Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in knee osteoarthritis (OA) (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Change in posterior medial femoral cartilage thickness by MRI at 30 weeks. Started Apr 2023; status: completed.
02
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2033230017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033230017.